This
spirochete was isolated from the grey matter of a an MS patient in
Germany in 1922 by Dr. Gabriel Steiner who invented
Steiner-Silver-Stain, a stain we still use today. His work on MS has
been all but forgotten.
Thank you goes to: Thomas Grier
Showing posts with label MS. Show all posts
Showing posts with label MS. Show all posts
Sunday, October 14, 2012
Monday, September 17, 2012
Magnetic resonance imaging signatures of vascular pathology in multiple sclerosis.
Read Full Article Here
Source
Magnetic Resonance Innovations, Inc., Detroit, MI, USA.Abstract
Venous vascular contributing factors to multiple sclerosis (MS) have been known for some time. Only recently has the scope of their potential role become more apparent with the theory of chronic cerebrospinal venous insufficiency (CCSVI). As research expands to further explore the role of vascular pathology in the MS population, it is expedient to review the evidence from an imaging perspective. In this paper, we review the current state-of-the-art methods using magnetic resonance imaging (MRI) as applied to imaging MS patients and CCSVI. This includes evaluating imaging signatures of vascular structure and flow as well as brain iron content. Upon review of the literature, we find that extracranial venous anomalies including stenosis, venous malformations, and collateralization of flow in the major veins of the neck have been observed to be prevalent in the MS population. Abnormal flow has been reported in MS patients both in major vessels using phase-contrast flow quantification and in the brain using perfusion-weighted imaging. We discuss the role of quantitative flow imaging and its potential in assessing possible biomarkers for abnormal flow. Finally, it has been suggested that the presence of high iron content may indirectly indicate progression of existing vascular pathology. To that end, we review the use of susceptibility-weighted imaging in monitoring iron in the thalamus, basal ganglia, and MS lesions.- PMID:
- 22971468
- [PubMed - in process]
LinkOut - more resources
Sunday, September 16, 2012
Multiple sclerosis is Lyme disease: Anatomy of a cover-up
Multiple sclerosis is Lyme disease: Anatomy of a cover-up
Perhaps the biggest ongoing medical
scandal of the past hundred years is the fact that it has been known
since 1911 that Multiple Sclerosis is caused by a bacterium, and that
the medical establishment covered this up, in order to make money
selling symptom relievers to MS patients. Since 1911, overwhelmingly
much medical research has been conducted where living Borrelia bacteria
were found in the brains of people who were diagnosed with MS.
Time and time again. By at least a dozen
medical researchers. In at least ten countries. Since 1911 – the past
one hundred years. Several older but also recent autopsy findings linked
to in this article found that all deceased MS patients’ brains harbored living Lyme spirochetes.
Even when tests, notorious for their large percentage of false
negatives were used on living MS patients, staggeringly many tested
positive for active Lyme borreliosis.
Then why isn’t this common knowledge? Surely, those thousands of MS experts and MS researchers can’t be all wrong?
Let’s examine the reality on the ground.
1. Multiple Sclerosis Societies.

2. Big Pharma.
Multinational pharmaceutical
corporations are the only ones doing MS research nowadays, mainly using
donations to MS societies. Those multinationals decide which researchers
get the cash. Researchers wanting to test the postulation of bacterial
etiology of MS are shunned as if they were crackpots. Big Pharma makes
billions a year on MS symptom relievers and they trickle millions down
to their footsoldiers, the “MS experts”. A cure would be a severe
financial blow. Even more so, because there is strong evidence that many
other neurological illnesses are caused by germs as well. Because due
to the phenomenon of immune privilege there is an inadequate immune
response in the brain and spinal cord, making these organs the ideal
place for certain slow-dividing spirochetal bacteria to entrench,
multiply and cause lesions. The entire concept of antibiotic-resistant,
hard-to-test-for chronic CNS infections leading to a dearth of
neurological syndromes has to be suppressed and what can’t be suppressed
will be craftily discredited. Better to give every expression of a
neurological infection its own name such as “MS”, “Alzheimers”,
“Parkinsons,” “ALS” and “Fibromyalgia”. And fund armies of ignorant
“experts” to obfuscate the issue, whilst boycotting, firing, censoring,
smearing and suing those few real experts that refuse to stay in line.
Big Pharma is in business to make money, and money is made when people
are ill, not when they’re healthy. Anyone standing in their way is
relegated to the sidelines. Patents are being bought and shelved so that
cures will never see the light of day.
3. Patient advocacy groups.
MS patient groups are, without
exception, populated with clueless individuals for the simple reason
that those who did their homework and read the relevant research have
been ostracized by the group. They always were and they always will,
because that’s how group dynamics works. As soon as you insist on
voicing an opinion outside of the mainstream, no matter how well argued –
you’ll be an outcast, a pariah. They don’t want rogue activists, “lone
nutters”, giving them a bad name. Also the advocacy groups are raking in
the dough and are run by folks whose main concern is that membership
dues are paid in time. No MS, no advocacy group. Of course if there ever
will emerge a lobby group insisting on more microbiological research
pertaining Multiple sclerosis, they’ll be branded “lunatic fringe” and
their efforts will be in vain.
4. MS “experts”.
Those “experts” get away with calling
themselves thus, because Big Pharma gives them their seal of approval in
the form of research grants and medical media exposure. However they
are only experts in doing exactly what Big Pharma wants them to do:
Obscuring the cause of Multiple Sclerosis! In return, the “experts” get
regular cash injections for their “promising research” and other goodies
such as all-in holidays to exotic destinations. There never will be a
cure for MS until the scandal breaks and new antibiotics are developed
that work better than the few currently available antibiotics that cross
the blood-brain barrier. As it stands, it has been more than twenty
years ago since any new antibiotic was developed. As soon as it was
found that Minocycline helped with MS, its manufacturer, Lederle,
tripled its price.
After long consideration I came to the
conclusion that at least a crucial part of this debâcle was due to a
real conspiracy – mainly a conspiracy of silence of those few MS
researchers bright enough to realize that the cause for MS has been
known for at least a hundred years. As is always the case with medical
cover-ups, it continues to exist due to a mix of ignorance,
indifference, cowardice and corruption. The saying goes: “Do not
attribute to malice that what can be adequately blamed on ignorance”.
All the “experts” really are interested in is being “experts”, not
curing Multiple sclerosis. However it still is a conspiracy. It is
completely normal for conspiracies to succeed because the lion share of
the people who could point it out don’t care, are too lazy to get
educated or feel too intimidated to stick out their necks.
Microbiologist Tom Grier calls them cowards. The fact that most
conspiracies are silently facilitated by an army of “useful idiots” with
a stake in it being kept under the rug does not make it any less a
conspiracy.
Evidence for a conspiracy of silence
Now I’ve given my opinion. You may find it harsh – I call it mild.
You don’t have to believe me,
when I say there is a conspiracy. Believe Alzheimer and Parkinson’s
disease expert Dr. Alan B. MacDonald M.D., Staff Pathologist at the St.
Catherine of Siena Medical Center. He wrote:
(published online 10 July 2006 in Volume 67, Issue 4, page 819-832 in Medical Hypotheses)
“Conventional thinking about spirochetal cyst forms is divided between two polar spheres of influence; one a majority community that completely denies the existence of spirochetal cyst forms, and a second group of academically persecuted
individuals who accepts the precepts of such antebellum scientists as
Schaudinn, Hoffman, Dutton, Levaditi, Balfour, Fantham, Noguchi,
McDonough, Hindle, Steiner, Ingraham, Coutts, Hampp, Warthin,
Ovcinnikov, and Delamater. Microscopic images of cystic spirochetes are
difficult to ignore, but as has been the case in this century, academic
“endowments” have nearly expunged all cystic spirochetal image data
from the current textbook versions of what is the truth about the
spirochetaceae. If the image database from the last century is
obliterated; many opportunities to diagnose will be lost. Variously
sized cystic spirochetal profiles within diseased nerve cells explain
the following structures: Lewy body of Parkinson’s disease, Pick
body, ALS spherical body, Alzheimer plaque. Borrelia infection is
therefore a unifying concept to explain diverse neurodegenerative
diseases, based not entirely on a corkscrew shaped profile in
diseased tissue, but based on small, medium and large caliber rounded
cystic profiles derived from pathogenic spirochetes which are hiding in
plain sight.”
Note how he claims that the majority of
researchers deny the existence of spirochetal cystic forms. Denial is
defined as knowing that something exists, but deliberately refusing to
acknowledge it for ulterior motives. By putting “endowments” between
question marks, he implies that Big Pharma bribes universities and publishers into censoring the very existence of spirochetal cysts from medical textbooks.
Click Here To See Full Article
Wednesday, September 12, 2012
Chlaymdial Pneumonia cause for MS?
Tuesday, September 11, 2012
Bartonella mimicks MS
Abstract
From Clinical Neurology and NeurosurgeryVolume 112, Issue 7 , Pages 625-628, September 2010
Rare infections mimicking MS
Vesna V. Brinar

Mario Habek
The diagnosis of multiple sclerosis (MS), despite well defined clinical criteria is not always simple. On many occasions it is difficult to differentiate MS from various non-MS idiopathic demyelinating disorders, specific and infectious inflammatory diseases or non-inflammatory demyelinating diseases. Clinicians should be aware of various clinical and MRI “red flags” that may point to the other diagnosis and demand further diagnostic evaluation. It is generally accepted that atypical clinical symptoms or atypical neuroimaging signs determine necessity for broad differential diagnostic work up. Of the infectious diseases that are most commonly mistaken for MS the clinician should take into account Whipple's disease, Lyme disease, Syphilis, HIV/AIDS, Brucellosis, HHV-6 infection, Hepatitis C, Mycoplasma and Creutzfeld-Jacob disease, among others. Cat scratch disease caused by Bartonella hensellae, Mediterranean spotted fever caused by Riketssia connore and Leptospirosis caused by different Leptospira serovars rarely cause focal neurological deficit and demyelinating MRI changes similar to MS. When atypical clinical and neuroimaging presentations are present, serology on rare infectious diseases that may mimic MS may be warranted. This review will focus on the infectious diseases mimicking MS with presentation of rare illustrative cases.
Sunday, September 9, 2012
Chlamydial Pneumonia, MS Cause?
Multiple sclerosis: a chronic infective cerebrospinal venulitis?
Abstract
The aetiology proposed for the development
of chronic cerebrospinal venous insufficiency (CCSVI) associated with
multiple
sclerosis (MS) has been the presence of congenital
truncular venous malformations. However, this hypothesis is not
consistent
with the epidemiology or geographical incidence of
MS and is not consistent with many of the ultrasonographic or
radiographical
findings of the venous disturbances found in MS
patients. However, the probability of a venous aetiology of MS remains
strong
based on evidence accumulated from the time the
disorder was first described.
The method used in this review was to
search PubMed for all past medical publications related to vascular,
venous, haematological,
epidemiological, biochemical, and genetic
investigations and treatments of MS.
Epidemiological and geographical findings
of prevalence of MS indicate the involvement of an infective agent. This
review
of the venous pathology associated with MS
describes a hypothesis that the pathogenesis of the venous disease could
be initiated
by a respiratory infective agent such as Chlamydophila pneumonia,
which causes a specific chronic persistent venulitis affecting the
cerebrospinal venous system. Secondary spread of the
agent would initially be via the lymphatic system
to specifically involve the azygos, internal jugular and vertebral
veins.
The hypothesis proposes mechanisms by which an
infective venous vasculitis could result in the specific neural damage,
metabolic,
immunological and vascular effects observed in MS.
The hypothesis described is consistent with many of the known facts of
MS pathogenesis and therefore provides a framework
for further research into a venous aetiology for the disease.
If MS does result from a chronic infective venulitis rather than a syndrome involving congenital truncular venous malformations,
then additional therapies to the currently used angioplasties will be required to optimize results.
Subscribe to:
Posts (Atom)